Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke
Top Cited Papers
Open Access
- 1 November 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 76 (11) , 1309-1318
Abstract
In 2010, the absolute number of people with a first stroke in the world was 16.9 million, and the number with stroke-related deaths was 5.9 million.1 Therefore, prevention of primary and secondary stroke is a priority. Elevated blood pressure (BP) is the most relevant and prevalent risk factor for stroke. Reduction in BP is the most effective intervention to prevent both primary and secondary strokes.2-7 In clinical trials for primary prevention of cardiovascular events, including stroke, the lower the better seems acceptable for stroke prevention in hypertensive patients, with less than 115 mm Hg suggested as the optimum target level of systolic BP.8 After a stroke, lowering BP in the chronic stage reduced the rates of recurrent stroke among both hypertensive and nonhypertensive patients in the Perindopril Protection Against Recurrent Stroke Study (PROGRESS).4 A post hoc analysis of the PROGRESS9 suggested that the optimum target level of systolic BP for the prevention of recurrent stroke is less than 120 mm Hg. In the Secondary Prevention of Small Subcortical Strokes (SPS3) randomized trial,10 the BP target was first evaluated in patients with recent stroke. The trial randomly assigned those with lacunar stroke to a systolic BP target of 130 to 149 mm Hg or less than 130 mm Hg, and the authors showed that the use of a systolic BP target less than 130 mm Hg is likely to be beneficial, especially for the prevention of hemorrhagic stroke. A recent meta-analysis demonstrated that strict and aggressive control of BP with achieved mean systolic and diastolic BP levels less than 130 mm Hg and less than 85 mm Hg, respectively, seemed to be beneficial for secondary prevention.7 In primary prevention, the Systolic Blood Pressure Intervention Trial (SPRINT)11 proved the benefit of aggressive BP control, demonstrating that targeting a systolic BP less than 120 mm Hg resulted in lower rates of major cardiovascular events compared with less than 140 mm Hg. Although a pooled analysis of 3 studies12-14 (3632 participants) comparing different systolic BP targets suggested that intensive BP lowering reduced the rate of recurrent stroke, no clinical trials to date have tested the effect of such aggressive BP lowering for secondary stroke prevention. Quiz Ref ID In the Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study, we herein tested the hypothesis that targeting intensive BP lowering of systolic and diastolic blood BP less than 120 mm Hg and less than 80 mm Hg, respectively, reduces the rate of stroke recurrence compared with a standard BP-lowering regimen.Keywords
This publication has 18 references indexed in Scilit:
- Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trialThe Lancet, 2013
- Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literatureHypertension Research, 2009
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine, 2008
- Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trialJournal Of Hypertension, 2006
- Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular EventsStroke, 2003
- Blood pressure and cardiovascular disease in the Asia Pacific regionJournal Of Hypertension, 2003
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Cardiovascular protection and blood pressure reduction: a meta-analysisThe Lancet, 2001
- Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackThe Lancet, 2001
- Effect of Antihypertensive Treatment in Patients Having Already Suffered From StrokeStroke, 1997